dihexa pnb 0408 human trial (PNB-0408) | C27H44N4O5 | CID 125355097 Dihexa | Drug Information, Uses,
Dihexa Drug Information, Uses, Side Effects, Chemistry DIHEXA POWDER (1 GRAM) UMBRELLA Labs dihexa human studies clinical trials DHX PNB 0408 DIHEXA Peptide Synthetic Dihexa (PNB 0408) Angiotensin IV analogue CAS NO.:1401708 83 5 GlpBio dihexa human trials Dihexa (also known as PNB 0408) is an experimental small molecule derived from Neoadjuvant trastuzumab deruxtecan alone or followed by paclitaxel, trastuzumab, and pertuzumab for high risk HER2 positive early breast cancer (DESTINY Breast11): a randomised, open label, multicentre, phase III trial Annals of Oncology
Pay in 4 interest-free payments of $6.23 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11





